Drug name - Xtampza Er

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9248195 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul, 2023

(9 months from now)

US8840928 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs Jul, 2023

(9 months from now)

US10525052 COLLEGIUM PHARM INC Abuse-deterrent drug formulations Jul, 2023

(9 months from now)

US9044398 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opiods and other drugs Jul, 2023

(9 months from now)

US9592200 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul, 2023

(9 months from now)

US9763883 COLLEGIUM PHARM INC Abuse-deterrent drug formulations Jul, 2023

(9 months from now)

US10525053 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs Jul, 2023

(9 months from now)

US8557291 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opioids and other drugs Mar, 2025

(2 years from now)

US8449909 COLLEGIUM PHARM INC Abuse-deterrent drug formulations Mar, 2025

(2 years from now)

US7399488 COLLEGIUM PHARM INC Abuse-deterrent pharmaceutical compositions of opiods and other drugs Mar, 2025

(2 years from now)

US7771707 COLLEGIUM PHARM INC Abuse-deterrent drug formulations Mar, 2025

(2 years from now)

US8758813 COLLEGIUM PHARM INC Abuse-deterrent drug formulations Jun, 2025

(2 years from now)

US9682075 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec, 2030

(8 years from now)

US10668060 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec, 2030

(8 years from now)

US10004729 COLLEGIUM PHARM INC Tamper-resistant pharmaceutical compositions of opioids and other drugs Dec, 2030

(8 years from now)

US10188644 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations Sep, 2036

(13 years from now)

US9968598 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations Sep, 2036

(13 years from now)

US10646485 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations Sep, 2036

(13 years from now)

US9737530 COLLEGIUM PHARM INC Process of making stable abuse-deterrent oral formulations Sep, 2036

(13 years from now)

Drugs and Companies using OXYCODONE ingredient

Treatment: Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
9MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
13.5MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
18MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
27MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
36MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.